From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Explosive Dossier: surely the FCA and SEC must act to stop the backdoor stockmarket comeback of Chris Cleverly

By Tom Winnifrith, The Sheriff of AIM | Thursday 25 March 2021


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


When your cousin James is a Foreign Office minister and tipped as a future Prime Minister and you mix freely among the Westminster great and good you might think that you are above the law. That certainly seems to be the case for Chris Cleverly who has spent the past five years lying to investors and raising cash on the back of it. Now he has a new con which he is trying to float on the Standard List of the London Stock Exchange via a backdoor reverse takeover into an insolvent company, and he has now roped in a US listed company which is already lying to its investors. The FCA and SEC must act at once. Cleverly’s crime spree started at AIM listed African Potash (AFPO).

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 09:07:33